Plain-English translation of NCT07200466 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a tool called ENDORISK that predicts a patient's individual risk of cancer spread to lymph nodes before surgery. The tool uses patient information to create a personalized risk score, which doctors then use to plan the best surgical approach. The study compares how well this new personalized approach works compared to standard care.
Right now, doctors struggle to predict before surgery which endometrial cancer patients have cancer that has spread to their lymph nodes. This uncertainty makes it hard to decide who needs lymph node removal surgery and who doesn't. This trial tests whether the personalized risk tool can help doctors and patients make clearer, more confident treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you join the intervention group, you would answer questions about your health and cancer characteristics, and doctors would use the ENDORISK calculator to give you a personalized risk score for lymph node involvement. Your doctor would then use this score to discuss with you whether lymph node surgery is recommended. You would also complete questionnaires about your quality of life and experience with the tool, and your health outcomes would be tracked over time.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Netherlands